Biotech news
Americas
Sanofi and Regeneron Pharmaceuticals must stop selling cholesterol-lowering medicine Praluent after Amgen obtained an injunction against the companies. 6 January 2017
Biotech
The English High Court has dismissed an application for summary judgment from pharmaceutical company AbbVie. 6 January 2017
Americas
US-based law firm Offit Kurman has boosted its expertise in Virginia with the appointment of Christopher Raimund as a principal in the intellectual property practice. 5 January 2017
Americas
Amgen secured victory yesterday as a US federal judge refused to throw out a ruling upholding the validity of two patents owned by the company. 4 January 2017
Americas
Pfizer has agreed a collaboration and licensing agreement with Sweden-based pharmaceutical company BioInvent International on cancer immunotherapy research. 22 December 2016
Pharma
A combination of patents, SPCs and regulatory exclusivities should be considered carefully in order to maximise the exclusivity available for cell therapies, as Glyn Truscott of Elkington + Fife explains. 22 December 2016
Asia-Pacific
Phylogica, an Australian drug discovery company, has extended its research collaboration and licensing agreement with Genentech to discover novel antibiotics. 21 December 2016
Americas
Biopharmaceutical company UCB Biopharma has filed a complaint against biotech developer MedImmune for alleged patent infringement. 15 December 2016
Biotech
Denmark-based ExpreS2ion Biotechnology and Abivax, a French biotechnology company, have entered into a service and commercial licensing agreement under which the companies will collaborate in their development of a treatment for Ebola. 15 December 2016
Americas
The US Supreme Court declined to hear a biosimilar case between Apotex and Amgen yesterday. 13 December 2016